Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Vero Cell-Derived Influenza Vaccine (VCIV) in Adults
NCT00566345Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Nov 2007
- Primary completion
- Jun 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated influenza vaccine (vero cell-derived) in influenza, sponsored by Resilience Government Services. Started Nov 2007; status: completed.
02
Drugs
inactivated influenza vaccine (vero cell-derived)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00566345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566345.